Argenica Therapeutics Ltd (AGN) — Net Asset Momentum
Argenica Therapeutics Ltd (AGN) recorded a net asset momentum of -48.1% as of December 2024, with net assets of AU$7.24 Million AUD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Argenica Therapeutics Ltd (AGN) shareholders funds for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Argenica Therapeutics Ltd Net Asset Momentum (2019–2024)
This chart tracks Argenica Therapeutics Ltd's year-over-year net asset growth across 6 annual reporting periods from 2019 to 2024. The most recent momentum reading is -48.1%, with net assets of AU$7.24 Million AUD as of December 2024. For live market cap and overall valuation, see AGN stock market capitalisation.
Annual Net Asset History for Argenica Therapeutics Ltd (2019–2024)
The table below shows the complete annual net asset history for Argenica Therapeutics Ltd from 2019 to 2024, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Argenica Therapeutics Ltd (AGN) tangible net worth to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (AUD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | AU$7.24 Million | AU$11.04 Million | AU$3.80 Million | ▼ -48.1% |
| 2023 | AU$13.95 Million | AU$16.38 Million | AU$2.43 Million | ▲ +82.0% |
| 2022 | AU$7.67 Million | AU$9.54 Million | AU$1.87 Million | ▼ -7.7% |
| 2021 | AU$8.31 Million | AU$9.04 Million | AU$735.91K | ▲ +21.3% |
| 2020 | AU$6.85 Million | AU$7.27 Million | AU$425.72K | ▲ +37116.6% |
| 2019 | AU$18.40K | AU$377.66K | AU$359.26K | — |